🔎 Trials Near Me

Hjem › Atopisk dermatitt (eksem) › Missouri

Kliniske studier for Atopisk dermatitt (eksem) i Missouri

7 studier for Atopisk dermatitt (eksem) søker deltakere på steder i Missouri.

Offisiell studietekst (engelsk)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

  • Red River Research Partners, Llc- Site Number : 8400054, Bolivar
  • Cleaver Dermatology- Site Number : 8400033, Kirksville
RekruttererObservasjonsstudie
Alder 12 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Saint Joseph
RekruttererFase 2
Alder 18 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06947993

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  • Saint Louis University, St Louis
RekruttererFase 3
Alder 2 til 11 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06807281

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

  • U.S. Dermatology Partners Lee's Summit, Lee's Summit
RekruttererObservasjonsstudie
Alder 12 til 89 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07645820

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  • Washington University School of Medicine - St. Louis /ID# 268545, St Louis
RekruttererFase 3
Alder 2 til 11 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06461897

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

  • MediSearch Clinical Trials /ID# 263579, Saint Joseph
RekruttererFase 3
Alder 18 til 63 · Alle kjønn · Oppdatert 6. jul. 2026 · NCT06389136

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 7057, Lee's Summit
RekruttererObservasjonsstudie
Alder 12 og eldre · Alle kjønn · Oppdatert 13. mar. 2026 · NCT06988605

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.